Effect of fermented lactic acid bacteria on antiallergic effect of artemisia princeps pampanini

Journal of Microbiology and Biotechnology

Volumn 16, Issue 9, 2006, Pages 1464-1467

  Shin, Yong Wook ^a   Bae, Eun Ah ^a   Lee, Bomi ^a   Min, Sung Won ^a   Baek, Nam In ^a   Ryu, Su No ^b   Chung, Hae Gon ^c   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Korea National Open University   (South Korea)

^c GangHwa Agricultural R and D Center   (South Korea)

Author keywords

Antiallergic effect; Artemisia princeps pampanini; Lactic acid bacteria; Passive cutaneous anaphylaxis reaction; Sajabalssuk

Indexed keywords

ANTIGEN; ARTEMISIA PRINCEPS EXTRACT; IMMUNOGLOBULIN E; NITRIC OXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTEMISIA; ARTEMISIA PRINCEPS; ARTICLE; ASTHMA; BIFIDOBACTERIUM LONGUM INFANTIS; CONTROLLED STUDY; DEGRANULATION; DERMATITIS; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; FERMENTATION MEDIUM; LACTIC ACID BACTERIUM; MOUSE; NONHUMAN; RHINITIS; SCRATCHING;

ARTEMISIA PRINCEPS; BIFIDOBACTERIUM LONGUM BV. INFANTIS;

EID: 33750170090     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bae, E. A., S. Y. Park, and D.-H. Kim. 2000. Constitutive β-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol. Pharm. Bull. 23: 1481-1485.
2. Bae, E.-A., N.-Y. Kim, M. J. Han, M.-K. Choo, and D.-H. Kim. 2003. Transformation of ginsenosides to compound K (IH-901) by lactic acid bacteria of human intestine. J. Microbiol. Biotechnol. 13: 9-14.
3. Bielory, L. 2004. Complementary and alternative interventions in asthma, allergy, and immunology. Ann. Allergy Asthma Immunol. 93(2 Suppl 1): S45-54.
4. Choo, M. K., E. K. Park, M. J. Han, and D. H. Kim. 2003. Antiallergic activity of ginseng and its ginsenoside. Planta Med. 69: 518-522.
5. Friedman, E. S., N. LaNatra, and M. J. Stiller. 2002. NSAIDs in dermatologic therapy: Review and preview. J. Cutan. Med. Surg. 6: 449-459.
6. Han, Y. O., M. J. Han, S. H. Park, and D. H. Kim. 2003. Protective effects of kakkalide from Flos puerariae on ethanol-induced lethality and hepatic injury are dependent on its biotransformation by human intestinal microflora. J. Pharmacol. Sci. 93: 331-336.
7. Kim, D. H. 2002. Herbal medicines are activated by intestinal microflora. Nat. Prod. Sci. 8: 35-43.
8. Kim, J.-M., J. E. Shin, E. A. Bae, M. J. Han, and D.-H. Kim. 2006. Inhibitory effect of ponciretin on Helicobacter pylori VacA toxin-induced vacuolation in HeLa cells. J. Microbiol. Biotechnol. 16: 46-51.
9. Kim, S. H., S. D. Lee, W. B. Kim, M. G. Lee, and N. D. Kim. 1997. Determination of a new antiulcer agent, eupatilin, in rat plasma, bile, urine, liver homogenate by high performance liquid chromatography. Res. Commun. Mol. Path. Pharmacol. 97: 165-170.
10. Kobashi, K. and T. Akao. 1997. Relation of intestinal bacteria to pharmacological effects of glycosides. Biosci. Microflora 16: 1-7.
11. Park, H.-Y., N.-Y. Kim, M. J. Han, E.-A. Bae, and D.-H. Kim. 2005. Purification and characterization of two novel β-D-glucuronidases converting glycyrrhizin to 18β-glycyrrhetinic acid-3-O-β-D-glucuronide from Streptococcus LJ-22. J. Microbiol. Biotechnol. 15: 792-799.
12. Park, S.-Y., J.-H. Kim, and D.-H. Kim. 2005. Purification and characterization of quercitrin-hydrolyzing ct-L-rhamnosidase from Fusobacterium K-60, a human intestinal bacterium. J. Microbiol. Biotechnol. 15: 519-524.
13. Reynolds, N. J., J. J. Voorhees, and G. H. Fisher. 1998. Cyclosporin A inhibits 12-O-tetradecanoyl-phorbol-13-acetate-induced cutaneous inflammation in severe combined immunodeficient mice that lack fuctional lymphocytes. Br. J. Dermatol. 139: 16-22.
14. Ryu, S. N., S. S. Han, J. J. Yang, H. G. Jeong, and S. S. Kang. 2005. Variation of eupatilin and jaceosidin content of mugwort. Korean J. Crop Sci. 50(S): 204-207.
15. Sakuma, S., Y. Higashi, N. Sato, T. Sasakawa, T. Sengoku, Y. Ohkubo, T. Amaya, and T. Goto. 2001. Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system (comparison with steroids). Int. Immunopharmacol. 1: 1219-1226.
16. Schafer-Korting, M., M. H. Schmid, and H. C. Korting. 1996. Topical glucocorticoids with improved risk-benefit ratio. Drug Safety 14: 375-385.
17. Shin, T. W., E. A. Bae, B. Lee, S. Min, J. H. Lee, N. I. Baek, S. N. Ryu, H. G. Chung, N. J. Kim, and D. H. Kim. 2006. Antiallergic effect of Artemisia princeps SJ-1 and SS-1 cultivated in Ganghwado. Nat. Prod. Sci. 12: in press.
18. Simons, F. E. R. 1992. The antiallergic effects of antihistamines (H1-receptor antagonists). J. Allergy Clin. Immunol. 90: 705-715.
19. Stevens, R. L. and K. F. Austen. 1989. Recent advances in the cellular and molecular biology of mast cells. Immunol. Today 10: 381-386.
20. Sugimoto, Y., K. Umakoshi, N. Nojiri, and C. Kamei. 1998. Effect of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice. Eur. J. Pharmacol. 351: 1-5.
21. Wuthrich, B. 1989. Epidemiology of the allergic diseases: Are they really on the increase? Int. Arch. Allergy Appl. Immunol. 90(Suppl. 1): 3-10.
22. Xiong, Q., S. Kadota, T. Tani, and T. Namba. 1996. Antioxidative effects of phenylethanoids from Cistanche deserticola. Chem. Pharm. Bull. 19: 1580-1585.